Global Breast Cancer Academy Experts
Nadia Harbeck, MD, PhD
Ludwig-Maximilian University of Munich, Germany
Prof Nadia Harbeck is head of the Breast Center and holds the chair for conservative oncology at the Ludwig-Maximilian University of Munich, Germany, following a post as head of the Breast Center at the University of Cologne from 2009 to 2011. After gaining her medical degree in 1989, she received her specialist training in obstetrics and gynecology at the Technical University of Munich, where she then worked as an associate professor and head of conservative senology until 2009.
Prof Harbeck is a member of the expert panel issuing the yearly updated evidence-based German Gynecological Oncology Working Group guidelines for breast cancer therapy and co-director of the West German Study Group. From 2009 to 2015, she served as an executive board member of the European Organisation for Research and Treatment of Cancer (EORTC) and as chair of the EORTC translational research division. She is principal investigator or steering committee member of numerous national and international clinical breast cancer trials focusing on novel targeted compounds. Her translational research centers on prognostic and predictive factors in breast cancer and other solid tumors. She also has a strong interest in eHealth and is a co-developer of the digital patient diary CANKADO.
For her clinical translational research, Prof Harbeck has received numerous awards, including the 2015 Bavarian Cancer Patient Award, the 2012 Claudia von Schilling Award, the 2002 AGO Schmidt-Matthiesen Award, a 2001 American Association for Cancer Research Award, and the 2001 American Society of Clinical Oncology Fellowship Merit Award for the highest-ranking abstract submitted.
Prof Harbeck is the author of more than 430 papers in peer-reviewed journals and is coordinating editor-in-chief of Breast Care. She is a panel member of several International Consensus Conferences such as Breast Cancer in Young Women (BCY), Advanced Breast Cancer (ABC), and the St Gallen Meeting for Early Breast Cancer.